3/31/2021Eucure Bio Announces Breakthru Phase I Results for Anti-CTLA-4 Therapy...

3/31/2021CDE Solicits Comments on Three Technical Guidelines for Nanomedicines

3/31/2021Financial-related Company News in Brief

3/30/2021China Plans "Unprecedented" Investment into TCM with Doubling Budget i...

3/30/2021Henlius and NeuPharma Enter License Deal for BRAF V600E Inhibitor

3/30/2021BMS and Huyabio Enter Global Clinical Trial Collaboration for Melanoma...

3/30/2021Snapshot of Chinese VMS OTC Market in 2020

3/30/2021PharmaDJ's China Market Approval Tracker: Feb 2021

3/29/2021Outlook of Chinese Biopharma Industry in 2021: Growth and Differentiat...

3/29/2021CDE Issues the Technical Guidelines for Drug Immunogenicity Research

3/29/2021HutchMed Initiates International Studies of IDH Inhibitor HMPL-306

3/29/2021Kazia Licenses Rights to Paxalisib in Greater China to Simcere

3/26/2021Boehringer Ingelheim Witness Sharp Growth in China Last Year

3/26/2021Kyowa Hakko Kirin Granted Chinese Approval for Additional Indication o...

3/26/2021Recent Executive Moves

3/25/2021Eli Lilly and Innovent Jointly Launched TYVYT (sintilimab injection) f...

3/25/2021CPIA Introduces the Pharmaceutical Industry Compliance Code

3/25/2021Shanghai Passes Law to Facilitate Traditional Chinese Medicine

3/24/2021HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combo with Ti...

3/24/2021China Declares Early Success in Expanding Online Medical Services

3/24/2021BMS to Offer Steeper Discount for Opdivo in China, Cutting Price to ...

3/24/2021Hutchmed Sells Non-core OTC Chinese JV with Baiyunshan for $169M

3/24/2021Ping An and Zhongshan Hospital Join Hands for Healthcare+Technology+Fi...

3/24/2021Pharma Manufacturing Industry Lag and Potential for China's Five-Year ...

3/23/2021Takeda Unveils Open Incubation Platform as Part of Its Digital Strateg...

3/23/2021China Introduces New Program for Early Access to New Drugs in the Grea...

3/23/2021Eucure Announces Breakthu Phase I Results for Anti-CTLA-4 in Combo wit...

3/23/2021EpimAb Raises $120M Pre-IPO with Global Expansion Aspirations

3/23/2021NMPA Revises Packages Insert of Mouse Nerve Growth Factor

3/23/2021NIFDC Issues the 2020 National Drug Sample Inspection Annual Report

Page:109/372 Total number of articles:11155: [First][<<] [107] [108] [109] [110] [111] [>>] [End]